CW October 2003Issue Number 10 October 2003 ISSN 10593802 Anti-tumor Vaccine for Melanoma Patients using Adenovirus VectorUsing an adenovirus vector to generate engineered tumor cells for vaccination in advanced melanoma patients is safe. The vaccine produces strong, specific, long-lasting antitumor activity.
Go to Previous Page Go to Next Page Source & Additional Reading G. Dranoff et al., Journal of Clinical Oncology, September 1, 2003. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW October 2003Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |